Maralixibat

ATC A05AX04 · 8 markets · 26 records

Maralixibat 8 markets · 26 records Forms

US 6 records · 6 strengths

CA 6 records · 6 strengths

GB 5 records · 5 strengths

ES 1 records · 1 strengths

TW 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名Livmarli ×4邁芮倍口服溶液 ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    HK 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名Livmarli 9.5mg/ml oral solution ×2

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        FR 1 records · 1 strengths

        • 9.5 mgliquidLIVMARLI 9,5 mg/mL, solution buvable also in US·CA·GB

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.